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CASE REPORT
Acinar cell carcinoma with fatty change arising from the pancreas
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ABSTRACT. Acinar cell carcinoma of the pancreas is a rare malignant tumour
developing from acinar cells, accounting for approximately 1% of pancreatic exocrine
tumours. We experienced a case of an acinar cell carcinoma with fatty change. To the
best of our knowledge, this is the first case report of an acinar cell carcinoma with fatty
change in the clinical literature.
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Acinar cell carcinoma (ACC) of the pancreas is a
malignant tumour developing from acinar cells. It is a
rare tumour accounting for approximately 1% of pan-
creatic exocrine tumours. ACC with fatty change is extre-
mely rare in the literature. This is a report on a 72-year-old
female who was found to have ACC with fatty change.
Case report
A 72-year-old female underwent a partial gastrectomy
with Billroth I for early gastric cancer in September 2009.
When a pancreatic mass was found during the 6-month
follow-up CT, the patient was admitted for further
investigation.
Test results showed elevated levels of alpha-fetoprotein
(AFP): 1945 IU ml21 (normal range: 0–7 IU ml21) and
normal levels of cancer antigen 19-9: 8.5 U ml21 (normal
range: 0–37 U ml21) and carcinoembryonic antigen
(CEA): 2.31 ng ml21 (normal range: 0–5 ng ml21).
An abdominal ultrasound showed a 2.5-cm hypoechoic
mass in the neck of the pancreas. The mass was ill-
delimitated and heterogeneous. Contrast-enhanced CT
showed a 2.5-cm mass in the neck of the pancreas with
distal pancreatic duct dilatation and parenchymal atro-
phy. Themass was adjacent to the portal vein and showed
less intense enhancement than the pancreas. No dilatation
of the bile ducts, focal hepatic lesions or abdominal
lymphadenopathies was found. The initial differential
diagnoses were pancreatic cancer and metastasis.
Positron emission tomography (PET) showed no
significant increase in fluorodeoxyglucose (FDG) uptake.
MRI showed a 2.5-cm hypovascular well-defined mass
at the neck of the pancreas with distal pancreatic duct
dilatation and parenchymal atrophy. This mass had low
signal intensity at T2 weighted imaging with fat sup-
pression, and had a fat component at in-phase and out-
of-phase images (Figure 1). The portal vein was com-
pressed and displaced by the mass, which remained
permeable without invasion.
A Whipple procedure was performed on the patient.
The specimen revealed an ill-defined lobulating mass of
1.961.7 cm, which was confined to the pancreas. Histo-
logically, the mass showed an acinar pattern of cells with
nucleoli (Figure 2). The tumour cells showed extensive
and various degrees of clear cell change and microvesi-
cular and macrovesicular fatty change. The tumour cells
showed strong and diffuse immunoreactivity for AFP and
were negative for CD56, chromogranin A and synapto-
physin. Pathological diagnosis was ACC with fatty
change.
Discussion
ACC is an uncommon solid epithelial exocrine
tumour. There are very few reports on this type of
tumour. ACC typically occurs during the fifth to seventh
decades of life, with a male predilection [1]. It can occur
in any part of the pancreas, but the most common site is
the head of the pancreas. A diagnosis of ACC can be
made on the characteristic positive periodic acid–Schiff
staining and immunohistochemical results.
Themost common histological patterns seen in ACC are
acinar and solid [2]. In a study by Klimstra et al [3], ACCs
were positive for at least one immunohistochemical
marker (i.e. trypsin, lipase, amylase, chymotrypsin, a1-
antitrypsin, keratin, epithelial membrane antigen, carci-
noembryonic antigen and AFP). ACCs, unlike endocrine
cell tumours, are believed to originate from transformed
acinar cells [2]. ACC with fatty change showed no
evidence of an endocrine differentiation and diffuse
immunoreactivity for AFP.
The imaging diagnosis of ACC varies owing to the
rarity of the disease: a well-marginated, large, solid mass
with a varied degree of cystic components; thin enhancing
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Figure 1. A 72-year-old female. (a) Contrast-enhanced CT showing a mass in the neck of the pancreas, which had less intense
enhancement than the pancreas. (b) Axial T2 weighted MRI with fat suppression showed low signal intensity in this mass. (c) In-
phase and (d) out-of-phase MRI showing a fat component in this mass.
(a) (b)
Figure 2. Microscopic findings. (a) Pancreatic mass showing an acinar pattern of cells with nucleoli. The tumour cells with
extensive and various degrees of clear cell change and fatty change (haematoxylin and eosin stain) (6100). (b) The tumour cells
showed strong and diffuse immunoreactivity for alpha-fetoprotein (6200).
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capsule; occasional central calcification; intralesional
haemorrhage and less intense enhancement than a normal
pancreas on both CT and MRI [4, 5]. ACC is unique
among pancreatic tumours as it is characterised by
increased AFP levels. Our case also showed increased
AFP levels and less intense enhancement than the
pancreas on both CT and MRI.
Although ACC shows increased blood AFP levels and
positive AFP stain, AFP can also be expressed by hepatoid
carcinomas. The pathogenesis of hepatoid carcinomas of
the pancreas is not fully understood. Paner et al [6] thought
that the potentiality of hepatic differentiation may arise
from any of the three main pancreatic cells (i.e. acinar,
ductal and islet cells). AFP can also be expressed by
pancreatic ductal carcinoma, acinar cell carcinoma, islet cell
tumour and poorly differentiated pancreatic adenocarci-
noma [7]. Therefore, the diagnosis of hepatoid carcinoma is
mainly provided by the cancer’s histological appearances
on haematoxylin and eosin-stained material [8].
In our case, fat-suppressed MRI confirmed that the
pancreatic mass contained a fat component. The pancreas
is a very rare location for fat-containing tumours [9].
Differential diagnosis of fat-containing pancreatic tu-
mours with direct invasion of pancreatic tissue should be
mentioned (i.e. malignant fibrous histiocytoma, leiomyo-
sarcoma, desmoids tumour, cystic teratoma, fibrolipoma,
liposarcoma and lipoblastoma) [10–12]. However, as in our
case, fat-containing tumours originating from the pancreas
may be ACC with fatty change.
To our knowledge, this is the first reported case of
ACC with fatty change. MRI is very important in
detecting the fat component of tumours. ACC with fatty
change must be considered in differential diagnosis of a
fat-containing pancreatic tumour with elevated levels of
AFP.
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